56 / 100

Prof. Margherita Fabbri | Modifying Awards | Best Researcher Award

Prof. Margherita Fabbri , CHU PURPAN , France

Margherita Fabbri, an accomplished neurologist and researcher, holds an MD from the University of Bologna, Italy, where she graduated with top honors. She further specialized in neurology and earned a PhD with distinction from the Faculty of Medicine at the University of Lisbon, Portugal. Her academic journey includes a Master’s in Pharmacoepidemiology from the Faculty of Bordeaux, France. Currently based at the University of Toulouse, France, Margherita serves as an Associate Professor and contributes significantly to the Movement Disorders Group at CHU Toulouse. Her research focuses on advanced Parkinsonā€™s Disease therapies, pharmacoepidemiology, and innovative treatments for Multiple System Atrophy. With over 100 papers published in peer-reviewed journals and an H-Index of 25, Margherita is dedicated to advancing clinical care and understanding in neurology, marked by her leadership in international professional societies

Professional Profile:

Google Scholar

 

šŸŽ“Education:

  1. MD (Medical Degree)
    • Year: 2007
    • Degree granting institution: University of Bologna, Italy
    • Final grade: 110 cum laude/110 cum laude
  2. Specialization in Neurology
    • Year: 2015
    • Degree granting institution: University of Bologna, Italy
    • Final grade: 70 cum laude/70 cum laude
  3. PhD
    • Year: 2019
    • Faculty of Medicine, University of Lisbon, Portugal
    • Degree: Praise with distinction (maximum score)
  4. Master in Pharmacoepidemiology
    • Year: 2022
    • Faculty of Bordeaux, France
    • Final grade: 17/20

šŸ¢Professional Career:

  • Neurologist
    • Institution:Ā Movement Disorders Group, Clinical Investigation Centre, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France
    • Starting Date:Ā March 2020
  • Associate Professor
    • Institution:Ā University of Toulouse, France
    • Starting Date:Ā September 2023

šŸ”¬Research Interests:

  1. Device-aided therapies for advanced Parkinsonā€™s Disease
  2. Pharmacoepidemiology
  3. Late-stage Parkinsonā€™s disease and multidisciplinary care
  4. Multiple system atrophy (MSA): new therapies and non-pharmacological treatments
  5. Clinical trials in movement disorders (PD and MSA)

Publication Top Notes:

  • The modern pre-levodopa era of Parkinsonā€™s disease: insights into motor complications from sub-Saharan Africa
    • Authors: R Cilia, A Akpalu, FS Sarfo, M Cham, M Amboni, E Cereda, M Fabbri, …
    • Cited By: 334
  • Amantadine in the treatment of Parkinson’s disease and other movement disorders
    • Authors: O Rascol, M Fabbri, W Poewe
    • Cited By: 113
  • Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis
    • Authors: M Fabbri, G Leodori, RM Fernandes, R Bhidayasiri, MJ Marti, C Colosimo, …
    • Cited By: 110
  • Opicapone for the treatment of Parkinson’s disease: a review of a new licensed medicine
    • Authors: M Fabbri, JJ Ferreira, A Lees, F Stocchi, W Poewe, E Tolosa, O Rascol
    • Cited By: 98
  • Do patients with late-stage Parkinson’s disease still respond to levodopa?
    • Authors: M Fabbri, M Coelho, D Abreu, LC Guedes, MM Rosa, N Costa, A Antonini, …
    • Cited By: 77

 

 

 

Prof. Margherita Fabbri | Modifying Awards | Best Researcher Award | 9343

You May Also Like